This compound is not a chemical in the traditional sense but rather appears to refer to a biological system involving the expression of the human CXCR2 receptor in HCT116 cells, which are a human colon cancer cell line. This engineered cellular model is primarily used in research to study the role of CXCR2—a chemokine receptor—in cancer progression, inflammation, and cell migration. Applications include investigating signaling pathways involved in tumor growth and metastasis, especially in colorectal cancer. It is also used to screen and evaluate potential therapeutic agents that target CXCR2, such as small molecule inhibitors or antibodies, to assess their impact on cell proliferation, migration, and survival. This model supports drug discovery and mechanistic studies in oncology and inflammatory disease research.